Business Description
TFBS Bioscience Inc
ISIN : TW0006939002
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.66 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 3.71 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.26 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.4 | |||||
3-Year EBITDA Growth Rate | 34.6 | |||||
3-Year EPS without NRI Growth Rate | 162.6 | |||||
3-Year Book Growth Rate | 72 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.8 | |||||
9-Day RSI | 55.24 | |||||
14-Day RSI | 53.1 | |||||
6-1 Month Momentum % | -11.33 | |||||
12-1 Month Momentum % | -17.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.89 | |||||
Quick Ratio | 9.77 | |||||
Cash Ratio | 8.9 | |||||
Days Inventory | 25.77 | |||||
Days Sales Outstanding | 95.45 | |||||
Days Payable | 19.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.13 | |||||
Forward Dividend Yield % | 0.13 | |||||
5-Year Yield-on-Cost % | 0.13 | |||||
Shareholder Yield % | -6.08 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.63 | |||||
Operating Margin % | -17.19 | |||||
Net Margin % | -10.68 | |||||
FCF Margin % | -97.26 | |||||
ROE % | -1.77 | |||||
ROA % | -1.58 | |||||
ROIC % | -7.18 | |||||
3-Year ROIIC % | -2.04 | |||||
ROC (Joel Greenblatt) % | -6.59 | |||||
ROCE % | -1.84 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.52 | |||||
PB Ratio | 1.08 | |||||
Price-to-Tangible-Book | 1.09 | |||||
Price-to-Operating-Cash-Flow | 53.43 | |||||
EV-to-EBIT | -27.47 | |||||
EV-to-EBITDA | 21.02 | |||||
EV-to-Revenue | 3.2 | |||||
EV-to-FCF | -3.26 | |||||
Price-to-Net-Current-Asset-Value | 1.92 | |||||
Price-to-Net-Cash | 2.19 | |||||
Earnings Yield (Greenblatt) % | -3.64 | |||||
FCF Yield % | -15.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TFBS Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 208.386 | ||
EPS (TTM) (NT$) | -0.65 | ||
Beta | 0 | ||
Volatility % | 17.2 | ||
14-Day RSI | 53.1 | ||
14-Day ATR (NT$) | 0.715201 | ||
20-Day SMA (NT$) | 38.08 | ||
12-1 Month Momentum % | -17.14 | ||
52-Week Range (NT$) | 36.1 - 53 | ||
Shares Outstanding (Mil) | 34.92 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TFBS Bioscience Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TFBS Bioscience Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
TFBS Bioscience Inc Frequently Asked Questions
What is TFBS Bioscience Inc(ROCO:6939)'s stock price today?
When is next earnings date of TFBS Bioscience Inc(ROCO:6939)?
Does TFBS Bioscience Inc(ROCO:6939) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |